V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20204640 | 20167341 | 0 | 60 | Palliative (P) | 2018-01-23 | 2018-04-03 | Cetuximab + FOLFIRI cycle 2 onwards | 99 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100309360 |
| 20204647 | 20167342 | 1.7 | 58 | Palliative (P) | 2016-05-21 | 2016-05-31 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100881301 |
| 20204650 | 20167343 | null | 70.3 | Palliative (P) | 2016-12-09 | 2016-12-10 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100677071 |
| 20204668 | 20167344 | 1.55 | 95 | null | 2019-04-23 | 2019-05-04 | CETUXIMAB + IRINOTECAN + MDG | N | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100915771 |
| 20204677 | 20167345 | 1.85 | 82.3 | Palliative (P) | 2020-07-14 | 2020-09-20 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100540702 |
| 20204687 | 20167346 | 1.81 | 59.2 | Palliative (P) | 2018-10-09 | 2019-02-25 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100960912 |
| 20204695 | 20167347 | 1.67 | 61.1 | null | 2016-07-08 | 2016-07-10 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101278535 |
| 20204697 | 20167348 | 1.55 | 81 | Palliative (P) | 2019-08-22 | 2019-09-05 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | DOCETAXEL | 101816018 |
| 20204698 | 20167349 | 1.53 | 82.3 | Curative (C) | 2016-09-15 | 2017-03-20 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100802939 |
| 20204707 | 20167350 | 1.89 | 92 | Palliative (P) | 2020-04-03 | 2020-05-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101117065 |
| 20204710 | 20167351 | 1.62 | 67 | null | 2019-06-30 | 2019-07-13 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100229177 |
| 20204719 | 20167352 | 1.61 | 83.7 | 03 | 2017-02-06 | 2018-02-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100246611 |
| 20204724 | 20167353 | 1.96 | 75.6 | Palliative (P) | 2019-04-28 | 2019-10-31 | Cetuximab + FOLFIRI cycle1 | 02 | N | DOCETAXEL | 100607484 |
| 20204725 | 20167354 | 1.61 | 51 | Palliative (P) | 2021-10-02 | 2021-10-10 | Docetaxel | 02 | N | DOCETAXEL | 101282570 |
| 20204726 | 20167355 | 1.52 | 79 | null | 2020-06-24 | 2020-08-09 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100473442 |
| 20204738 | 20167356 | 1.79 | 54.7 | Adjuvant (A) | 2016-05-06 | 2016-10-30 | Docetaxel | 02 | N | DOCETAXEL | 100219343 |
| 20204748 | 20167357 | 1.67 | 74 | 03 | 2019-07-10 | 2019-09-07 | Docetaxel | 02 | N | DOCETAXEL | 101715013 |
| 20204754 | 20167358 | 1.6 | 97.8 | Palliative (P) | 2019-08-01 | 2019-08-08 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CAPECITABINE + GEMCITABINE | 101744332 |
| 20204760 | 20167359 | 0 | 75.2 | Curative (C) | 2021-04-05 | 2021-08-14 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101219360 |
| 20204762 | 20167360 | 1.62 | 79.6 | Palliative (P) | 2018-11-06 | 2018-11-27 | Cetuximab + FOLFIRI cycle1 | 02 | null | DOCETAXEL | 100006961 |
| 20204773 | 20167361 | 1.66 | 74.7 | Palliative (P) | 2016-12-24 | 2016-12-24 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100624652 |
| 20204777 | 20167362 | 1.66 | 78.5 | null | 2019-11-26 | 2019-12-02 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100845907 |
| 20204784 | 20167363 | 1.68 | 62.9 | Palliative (P) | 2018-01-04 | 2018-06-20 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101467058 |
| 20204807 | 20167364 | 1.67 | 55.4 | Adjuvant (A) | 2019-06-19 | 2019-07-16 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100428652 |
| 20204817 | 20167365 | null | 67.55 | null | 2018-05-02 | 2018-09-20 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | DOCETAXEL | 100182397 |
| 20204845 | 20167366 | 1.74 | 70 | null | 2021-04-22 | 2022-04-24 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100673378 |
| 20204862 | 20167367 | 1.74 | 68.2 | Palliative (P) | 2018-09-09 | 2018-09-11 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100861001 |
| 20204869 | 20167368 | 1.61 | 65 | null | 2019-05-02 | 2019-05-17 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101659922 |
| 20204878 | 20167369 | 1.61 | 70.45 | Palliative (P) | 2019-10-27 | 2019-10-28 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 101834041 |
| 20204880 | 20167370 | 1.7 | 49.8 | Palliative (P) | 2016-10-12 | 2018-05-19 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101503995 |
| 20204887 | 20167371 | 1.66 | 77 | Palliative (P) | 2021-07-25 | 2021-08-11 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101034762 |
| 20204899 | 20167372 | 1.6 | null | null | 2016-09-14 | 2016-10-05 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100027348 |
| 20204901 | 20167373 | 1.9 | 89.2 | Palliative (P) | 2015-10-06 | 2016-08-12 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | DOCETAXEL | 101439217 |
| 20204917 | 20167374 | 1.7 | 56.2 | Palliative (P) | 2016-07-11 | 2016-07-17 | Docetaxel | 02 | N | DOCETAXEL | 100125248 |
| 20204938 | 20167375 | 1.7 | 73 | Palliative (P) | 2021-12-23 | 2021-12-23 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CAPECITABINE + GEMCITABINE | 101341226 |
| 20204941 | 20167376 | 1.76 | 70 | Palliative (P) | 2018-01-26 | 2018-02-04 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101770339 |
| 20204956 | 20167377 | 1.7 | 71 | Palliative (P) | 2019-11-07 | 2019-12-10 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100860186 |
| 20204970 | 20167378 | 1.69 | 93.2 | Palliative (P) | 2018-09-13 | 2018-09-13 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101092036 |
| 20205010 | 20167379 | 1.6 | 59.6 | null | 2016-06-25 | 2016-07-07 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101245632 |
| 20205014 | 20167380 | 1.62 | 99.2 | Neo-adjuvant (N) | 2017-01-12 | 2017-01-17 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100219317 |
| 20205019 | 20167381 | 1.51 | 61.6 | Palliative (P) | 2022-01-23 | 2022-02-11 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101515766 |
| 20205034 | 20167382 | 1.77 | 58.2 | Palliative (P) | 2016-06-26 | 2016-07-02 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100777010 |
| 20205054 | 20167383 | 1.66 | 61.9 | Palliative (P) | 2020-09-06 | 2022-03-10 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100905075 |
| 20205067 | 20167384 | 1.83 | 61 | Palliative (P) | 2018-03-14 | 2018-06-24 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | DOCETAXEL | 100185038 |
| 20205070 | 20167385 | 1.7 | 81.6 | null | 2019-01-16 | 2019-03-01 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100911532 |
| 20205080 | 20167386 | 1.86 | 96 | Adjuvant (A) | 2016-07-02 | 2016-07-02 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100850927 |
| 20205081 | 20167387 | 1.67 | 54.4 | Palliative (P) | 2018-04-09 | 2018-04-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100167320 |
| 20205087 | 20167388 | 1.85 | 89.6 | Palliative (P) | 2022-02-27 | 2022-03-04 | Docetaxel | 02 | N | DOCETAXEL | 101754139 |
| 20205092 | 20167389 | 1.6 | 88 | Palliative (P) | 2021-12-11 | 2021-12-26 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100291238 |
| 20205103 | 20167390 | 1.66 | 52.9 | Adjuvant (A) | 2019-09-21 | 2020-01-05 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101705121 |